Serina Therapeutics (Serina Therapeutics) Accounts Payable & Accrued Expense : $3.97 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Accounts Payable & Accrued Expense?

Serina Therapeutics's quarterly accounts payable & accrued expense increased from Dec. 2022 ($0.16 Mil) to Jun. 2023 ($0.66 Mil) and increased from Jun. 2023 ($0.66 Mil) to Mar. 2024 ($3.97 Mil).

Serina Therapeutics's annual accounts payable & accrued expense increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.16 Mil) but then declined from Dec. 2021 ($0.16 Mil) to Dec. 2022 ($0.16 Mil).

Serina Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Serina Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Accounts Payable & Accrued Expense Chart

Serina Therapeutics Annual Data

Trend

Dec21

Dec22

Accounts Payable & Accrued Expense

0.16

Serina Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Mar24
Accounts Payable & Accrued Expense	0.16	-	0.16	0.66	3.97

Serina Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Serina Therapeutics (Serina Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

2BO:Germany

Address

601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806

Website

https://www.serinatherapeutics.com

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines

From GuruFocus

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse� for Advanced Parkinson's Disease

By Marketwired • 05-15-2024